
|Videos|April 27, 2022
Aurion BioTech presents cell therapy findings with published clinical data
Author(s)Kassi Filkins
Greg Kunst, president and CEO of Aurion BioTech, shares a company update on endothelial cell therapy trials, clinical plans and upcoming data.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
3
Alcon raises offer in amended deal to acquire STAAR Surgical
4
Study maps thermal dynamics of glaucoma laser treatments
5













































.png)


